Microbiome companies study and develop products based on the communities of microorganisms associated with humans, animals and the environment. Their work supports therapeutics, diagnostics, nutrition, personal care and biological research.
This category includes companies working on:
Browse 30 UK microbiome companies below.
Microbiome modulator ingredients for metabolic health and disease prevention
OptiBiotix Health is a biotechnology company developing and licensing microbiome modulator products for use in food ingredients, dietary supplements, and nutraceuticals. Its portfolio includes patented prebiotic and probiotic formulations targeting weight management, cholesterol reduction, cardiovascular health, and…
Clinical-stage therapeutics for advanced liver disease
Yaqrit is a clinical-stage biotechnology company developing treatments for patients with advanced liver disease, including cirrhosis and acute-on-chronic liver failure. Its pipeline includes an oral ammonia scavenger for hepatic encephalopathy, an extracorporeal liver support device, and a microbiome-based…
Contract research and analytical services for food and health industries
QIB Extra is a wholly owned commercial subsidiary of Quadram Institute Bioscience, providing contract research, analytical services, and consultancy to companies in the food, nutrition, and health sectors. Operating from Norwich Research Park, it gives commercial clients access to the facilities and scientific…
Engineered bacteria to remodel the tumour microenvironment
Neobe Therapeutics is a UK synthetic biology company developing programmable live biotherapeutics that colonise solid tumours and disrupt the local microenvironment to enable immune cell infiltration. The platform engineers tumour-colonising bacteria to break down stromal barriers that exclude immune cells, aiming to…
AI-powered microbiome and phage therapy platform for gut disorders
GutSee Health is a biotechnology company developing precision microbiome therapies for gut disorders including irritable bowel syndrome and inflammatory bowel disease. Its AI discovery platform integrates multi-omics and microbiome data to identify molecular disease signatures and therapeutic targets. A parallel…
Microbiome platform optimising hydroponic crop performance
Concert Bio is an agricultural biotechnology company developing microbial products to optimise crop performance in hydroponic greenhouses. Its platform combines the world's largest hydroponic microbiome database with machine learning to identify beneficial microbes tailored for soilless growing systems. The company's…
Clinical skin microbiome testing and multi-omic ingredient analysis platform
Sequential Skin is a biotechnology company providing non-invasive clinical microbiome testing and multi-omic analysis services to the personal care and pharmaceutical industries. Using patch-based sampling and next-generation sequencing, the company quantifies how ingredients and formulations affect the skin…
Contract microbial whole genome sequencing and metagenomics service
MicrobesNG Ltd is a UK-based contract sequencing service provider specialising in microbial whole genome and metagenome sequencing. The company processes bacterial, fungal, and viral samples using Illumina short-read and Oxford Nanopore long-read platforms, with DNA extraction and bioinformatics analysis included as…
Living building materials and microbial construction biotechnology research
Hub for Biotechnology in the Built Environment is a Newcastle and Northumbria University research collaboration developing biologically enabled building materials and environmental technologies. Its work spans microbial mineralisation, self-healing construction materials, mycelium-based structures, building…
Gut microbiome tests predicting biologic drug response in IBD
AlphaBiomics is a precision medicine company developing diagnostics that analyse the gut microbiome to guide treatment decisions. Its lead test uses a stool sample collected at home and machine learning analysis of microbial sequencing data to predict which patients with inflammatory bowel disease are likely to…
AI-driven skin microbiome platform for skincare and drug discovery
Biotix is a biotechnology company applying artificial intelligence and microbiome science to discover and develop novel approaches for skin health. Its AI platform analyses proprietary microbiome and clinical datasets to identify beneficial skin microbes and their metabolites, supporting both a commercial skincare…
Canine gut microbiome testing and personalised supplement service
BIOME9 is a canine health company providing at-home gut microbiome testing and personalised supplement plans for dogs. Using stool sample analysis and AI-assisted interpretation, the company generates detailed gut health reports identifying microbial imbalances and tailored dietary recommendations. Operating as the…
AI-powered gut microbiome analysis for personalised clinical nutrition
Enbiosis is a biotechnology company combining whole-genome gut microbiome sequencing with artificial intelligence to generate personalised nutrition, dietary, and supplement recommendations for patients with gastrointestinal disorders. Its B2B platform is used by healthcare professionals including gastroenterologists…
Food and gut health bioscience research on Norwich Research Park
Quadram Institute Bioscience is a BBSRC-funded independent research organisation focused on the interactions between food, gut microbiota, and human health. Operating within the Quadram Institute, a partnership with the University of East Anglia, Norfolk and Norwich University Hospitals, and BBSRC, it conducts…
Targeted antibacterial gel for gum disease
Sysora Health develops a targeted antibacterial gel for periodontitis, a severe form of gum disease. Its approach aims to eliminate Porphyromonas gingivalis, a bacterium implicated in gum inflammation, while preserving beneficial microorganisms in the oral microbiome. The company is investigating selective bacterial…
Oral microbiome therapeutics for gastrointestinal and hepatic disease
EnteroBiotix is a clinical-stage biopharmaceutical company developing orally delivered, full-spectrum microbiome therapeutics for diseases linked to gut microbiome disruption. Its lead asset EBX-102-02 demonstrated clinically meaningful improvements in irritable bowel syndrome in Phase 2a trials, with a Phase 2b study…
Breast milk microbiome biotech developing infant health solutions
BoobyBiome Ltd is a biotechnology company developing products to give formula-fed and high-risk infants access to the beneficial microbiome of breast milk. Its platform is built on the world's first high-resolution breast milk microbiome database and a proprietary biobank of strains from hundreds of donor samples. Its…
Web-based bioinformatics platform for microbial genomics and bioprocessing
MORF-Bio is a company developing a web-based software platform that makes microbial bioinformatics and bioprocess data analysis accessible to researchers and industry without specialist coding skills. Its tools cover microbial genome assembly and comparison, metabolic modelling, fermentation data visualisation and…
Probiotic contract manufacturer and Lab4 platform developer
Cultech is a Welsh contract developer and manufacturer of probiotic and nutritional supplement products, operating one of the world's most advanced probiotic manufacturing facilities at its Port Talbot site. The company owns the proprietary Lab4 probiotic consortium, backed by over 35 clinical trials and ten PhD…
Developer and manufacturer of clinically proven prebiotic ingredients
Clasado Biosciences is a UK-based developer and manufacturer of a proprietary galactooligosaccharide prebiotic ingredient, backed by over 125 scientific publications and more than 20 clinical trials. Operating exclusively as a B2B ingredient supplier, the company serves global supplement, functional food, beverage,…